דיאנה 35

Country: Israel

Language: Hebrew

Source: Ministry of Health

Buy It Now

Active ingredient:

CYPROTERONE ACETATE; ETHINYLESTRADIOL

Available from:

BAYER ISRAEL LTD

ATC code:

G03HB01

Pharmaceutical form:

טבליה

Composition:

ETHINYLESTRADIOL 35 MCG; CYPROTERONE ACETATE 2 MG

Administration route:

פומי

Prescription type:

מרשם נדרש

Manufactured by:

BAYER WEIMAR GMBH UND CO.KG, GERMANY

Therapeutic group:

CYPROTERONE AND ESTROGEN

Therapeutic area:

CYPROTERONE AND ESTROGEN

Therapeutic indications:

Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. For the treatment of acne, Diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.

Authorization date:

2013-05-31

Patient Information leaflet

                                (
)
"
-
1986
35
:
35
"
(
ethinylestradiol 35 mcg
)
2
"
(
cyproterone acetate 2 mg
)
:
6
"
"
2
"
"
.
.
.
,
.
.
.
.
1
)
?
35
(
-
)
,
.
35
.
35
.
:
35
-
.
.
,
,
(
)
.
,
.
35
.
35
,
,
,
.
35
,
.
35
,
/
.
35
,
HIV
(
)
.
.
(2 :
•
(
)
.
,
6
"
."
•
•
•
•
•
(
)
(
-
,)
(
)
•
(
)
-
(
[
]
)
"
-
"
(
)
•
(
)
-
•
.
:
–
-
–
-
–
(
)
•
(
C
)
•
(
)
•
-
•
•
C
(
C
)
/
/
,
,
/
/
/
)
"
/
)"
.
•
-
(
-
.)
35
.
.
,
35
,
.
,
.
.
35
,
.
35
,
.
.
35
-
,
,
-
,
35
.
35
-
35
,
.
35
,
.
o
,
-
o
o
o
o
_ (_
_מ_
_ _
_ _
_ )_
o
o
o
_(_
_פ_
_)_
,
_(_
_מ_
_פ_
_)_
,
o
_(_
_מ_
_)_
,
(
"
35
"
)
o
35
(
4
"
"
)
o
/
/ ,
.
,)(
.
35
.
.
,
35
,
,
.
:
,
35
,
.
.
,
.
•
?
.
"
(
)
"
4
"
"
.
35
.
.
)
(
35
(
,
.)
35
35
.
,
1-2%
.
(
"
"
)
.
,
(
)
.
,
.
.
.
35
.
–
100,000
35
,
-
5
10
.
–
100,000
35
,
40
.
–
100,000
,
60
.
:
–
;
–
.
35
,
,
35
;
–
,
;
–
;
–
,
,
;
–
;
–
;
–
,
;
–
.
,
35
,
.
35
.
35
.
.
,
-
,
.
.
:
–
;
–
.
35
,
,
35
;
–
;
–
;
–
-
;
–
(
;)
–
;
–
(
,
)
;
–
;
–
;
–
;
–
.
:
,
,
:
•
;
•
,
;
•
;
•
,
,
;
•
,
;
•
;
•
,
;
•
;
•
;
•
;
•
.
.
,
.
,
,
35
.
,
(
)
,
,
(
4
"
"
)
.
35
,
,
,
35
,
.
,
35
-
-
35
.
.
,
35
,
.
35
,
-
10
.
40
,
35
.
:
–
10,000
35
,
-
16
35
.
–
10,000
35
5
-
20
,
-
17-18
35
.
–
10,000
35
,
-
100
45
.
–
10,000
35
5
-
30
,
-
110
45
.
:
•
(
,
)
•
,
.
35
,
,
.
,
35
.
,
_(_
_)_
.
35
.
(
25
) "
,
.)
(
,
,
35
,
(
2
.)"
" /
,
,
,
(
)
.
,
(
,)
35
.
(
)
,
,
,
.
,
.
:
•
35
-
•
,
•
.
:
•
(
)
(
,
,
,
,
,
)
•
(
,
)
•
HIV
(
)
C
(
non-nucleoside
reverse transcriptase
,
,
,
,
)
•
(
,
,
)
•
,
(
)
•
-
(
)
•
-
St. John
’
s wort
(
)
,
35
.
,
.
35
,
:
•
•
'
(
)
•
(
)
•
(
/
)
.
35
C
)
C
)
/
/
,
,
/
/
/
(
ALT
)
.
.
35
(
2
"
)"
.
35
,
.
,
35
-
,
,
35
,
-
.
35
.
35
.
,
,
.
,
.
.
35
.
35
.
.
,
6
.
35
.
35
.
35
.
.
35
.
,
(
.)
35
,
35
;
[
2
"
(
.]")
–
.
35
•
,
.
,
,
,
.
35
•
,
-
35
.
•
(
PAP SMEAR
)
.
•
–
,
.
•
-
,
35
,
.
•
,
.
35
.
(
2
–
)
.
35
.
•
35
35
,
(
,
.)
35
.
-
-
,
35
.
(3
?
.
.
35
.
,
35
,

                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet English 29-05-2022
Public Assessment Report Public Assessment Report English 17-08-2016
Patient Information leaflet Patient Information leaflet Arabic 29-05-2022

View documents history